Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist Effectiveness in School-Based Intervention
NCT00192218Phase 4Completed
- Sponsor
- MedImmune
- Start
- Oct 2004
- Primary completion
- Apr 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoints: Workdays lost by adults and School days lost by children. Started Oct 2004; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192218.